Emendo Biotherapeutics, the biotech startup focused on using gene-editing for the development of medicine, has raised $61M in Series B funding from investors that include Takeda Ventures and AnGes. Emendo Biotherapeutics was founded in 2015.
Nominations are now open for AlleyWatch’s 2020 NYC Tech Influencers feature.
Know someone amazing who belongs on this list? Nominate them today here. Nominations open until 2/4. Looking to drive targeted response from the NYC Tech community at scale, learn more about partnering with AlleyWatch on this initiative here.